Back to Search Results

Radioimmunotherapy Using Oxide Nanoparticles

Radioimmunotherapy (RIT) is an important approach to treating several non-solid tumor cancers or illness. The primary limitation of RIT is the unintentional release of the radionuclide or daughter products into normal tissues, causing radiotoxicity. This limitation is addressed through a novel nanoparticle delivery system, which guarantees containment of the radionuclide and daughter products, while still allowing efficient delivery of the radionuclide to targeted tissues as a monoclonal antibody (mAb) conjugate.

Chemical Sciences Division
Oak Ridge National Laboratory
Oak Ridge National Laboratory
Phone: (865) 241-6564
Chemical Sciences
Search Home Help About InSpire